{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-24-047461","form_type":"8-K","ticker":"AIFC","cik":"0000862861","company_name":"AI Financial Corp","filed_at":"2024-11-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:11.173570+00:00","generated_at":"2026-05-30T01:26:44.530971+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"ALT5 Sigma reports record Q3 fintech revenue of $4.94M; net income $714K","bullets":["Q3 fintech revenue $4.94M, gross profit $2.39M (~48% margin), net income $714K.","Adjusted EBITDA of fintech ~$890K; transaction volume exceeded $600M during Q3.","Board approved separation of fintech and biotech (Alyea Therapeutics) into independent entities, expected H1 2025.","Peter Tassiopoulos appointed CEO Aug 26; Ron Pitters joined board in November.","Post-quarter acquisition of third-party IP to accelerate new feature launches in Q4 and FY2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-24-047461","json":"https://secwatch.observer/filing/0001628280-24-047461.json","markdown":"https://secwatch.observer/filing/0001628280-24-047461.md","text":"https://secwatch.observer/filing/0001628280-24-047461.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/862861/000162828024047461/0001628280-24-047461-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/862861/000162828024047461/jan-20241112.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T01:26:44.530971+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}